NKGen Biotech, Inc.
CIK: 0001845459
Company Information
Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 3001 DAIMLER ST,, SANTA ANA, CA, 92705
Mailing Address 3001 DAIMLER ST,, SANTA ANA, CA, 92705
Phone (949) 396-6830
Fiscal Year End 1231
EIN 000000000
Financial Overview
FY2024
-$44.29M
Net Income
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | February 5, 2026 | View on SEC |
| 8-K Current report of material events | January 26, 2026 | View on SEC |
| 10-Q Quarterly financial report | January 20, 2026 | View on SEC |
| 8-K Current report of material events | January 16, 2026 | View on SEC |
| 8-K Current report of material events | January 9, 2026 | View on SEC |
| 10-K Annual financial report | October 8, 2025 | View on SEC |
| 8-K Current report of material events | September 29, 2025 | View on SEC |
| 8-K Current report of material events | September 24, 2025 | View on SEC |
| 8-K Current report of material events | September 9, 2025 | View on SEC |
| 8-K Current report of material events | July 17, 2025 | View on SEC |
Annual Reports
10-K October 8, 2025
- Encouraging early results for Alzheimer’s treatment
- Secured partnership with larger pharmaceutical company
Material Events
8-K Acquisition January 9, 2026
High Impact
- NKGen Biotech, Inc. secured a significant loan of over $25.8 million from AlpineBrook Capital.
- The loan primarily formalizes past cash advances used to acquire a majority stake in NKGen Biotech Korea Co., Ltd.
Related Companies
Companies in the same industry (SIC: 2836)
AMGEN INC
AMGN Biological Products, (No Diagnostic Substances)
INTENSITY THERAPEUTICS, INC.
INTS Biological Products, (No Diagnostic Substances)
Vitro Biopharma, Inc.
Biological Products, (No Diagnostic Substances)
Surrozen, Inc./DE
SRZN Biological Products, (No Diagnostic Substances)
Twist Bioscience Corp
TWST Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.